PENTREXCILINA SEVERE ALLERGY- diphenhydramine hydrochloride tablet, film coated

Pentrexcilina Severe Allergy by

Drug Labeling and Warnings

Pentrexcilina Severe Allergy by is a Otc medication manufactured, distributed, or labeled by OPMX LLC, Health Pharma USA LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Drug Facts

Drug Facts

Active ingredient (in each tablet)

Diphenhydramine HCl 25mg

Purpose

Antihistamine

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

• runny nose
• sneezing
• itchy, watery eyes
• itchy nose or throat
• temporarily relieves these symptoms of the
• common cold

Warnings

Do not use

• with any other product containing dyphenhydramine, even one used on skin
• to make a child sleepy

ask a doctor before use if you have

• trouble urinating due to an enlarged prostate gland
• a breathing problem such as emphysema or chronic bronchitis

ask your doctor or pharmacist before use if you are

• taking sedative or tranquilizers

When using this product

• marked drowsiness may occur
• avoid alcoholic drinks
• excitability may occur, especially in children
• alcohol, sedatives and tranquilizers may increase drowsiness
• be careful when driving a motor vehicle or operating machinery

If pregnant or breast-feeding,

ask a professional before use

Keep out of reach of children.

OVERDOSE WARNING

In case of overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as children even if you do not notice any signs or symptoms.

Directions

• take every 4 to 6 hours, or as directed by a doctor
• do not take more than 6 doses in 24 hours

​Adults and children 12 years and over: 1 or 2 caplets

Children 6 to under 12 years of age: 1 caplet

Children under 6 years of age: do not use

Other information

• Each caplet contains: Calcium 23.52 mg
• store at controlled room temperature 20°-25°C (68°-77°F).
• read all product information before using

TAMPER EVIDENT: Do not use if imprinted safety seal is broken or missing.

Inactive ingredients

Colloidal silicon Dioxide, Croscarmellose Sodium, D & C Red #27, Dicalcium Phosphate, Lecithin, Magnesium stearate, Microcrystalline cellulose, Polyvinyl alcohol, Titanium dioxide, Talc.

Questions or comments?

Call (619) 600-5632

Monday through Friday 9AM- 5PM EST

Principal display Panel

Daytime Xtreme Allergy Relief

Cetirizine HCl 10mg

Non-Drowsy

NDC: 69729-137-14

14 Tablets

DUO PACK

PENTREXCILINA

ALL DAY & ALL NIGHT

24 HOUR ALLERGY RELIEF OF:

Sneezing/ Estornudos
Runny nose/ Escurrimiento nasal
Itchy, watery eyes/ Irritación y ojos llorosos
Itchy throat/ Picazón en garganta

Nighttime Severe Allergy Relief

Sleep-aid

Diphenhydramine HCl 25mg

NDC: 69729-106-14

14 Caplets

Made for RRX

Exclusively distributed by:

OPMX

Chula Vista CA 91910

Phone: 619-600-5632

INGREDIENTS AND APPEARANCE

PENTREXCILINA SEVERE ALLERGY 
diphenhydramine hydrochloride tablet, film coated

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 69729-106
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
DIPHENHYDRAMINE HYDROCHLORIDE (UNII: TC2D6JAD40) (DIPHENHYDRAMINE - UNII:8GTS82S83M)	DIPHENHYDRAMINE HYDROCHLORIDE	25 mg

Inactive Ingredients
Ingredient Name	Strength
MAGNESIUM STEARATE (UNII: 70097M6I30)
ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)
D&C RED NO. 27 (UNII: 2LRS185U6K)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)
TALC (UNII: 7SEV7J4R1U)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
LECITHIN, SOYBEAN (UNII: 1DI56QDM62)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)

Product Characteristics
Color	pink	Score	no score
Shape	OVAL	Size	10mm
Flavor		Imprint Code	D;25
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 69729-106-14	14 in 1 BOTTLE; Type 0: Not a Combination Product	11/15/2024

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M012	11/15/2024

Labeler - OPMX LLC (029918743)

Establishment
Name	Address	ID/FEI	Business Operations
Health Pharma USA LLC		080804485	manufacture(69729-106)